MicroRNA expression signatures in solid malignancies
- PMID: 22647360
- DOI: 10.1097/PPO.0b013e318258b5f4
MicroRNA expression signatures in solid malignancies
Abstract
An ongoing challenge in cancer research is represented by the identification of new specific clinical molecular markers and pharmacological targets. During the last 10 years, microRNAs (miRNAs) have become one of the hottest subjects in the area of cancer genomics. MicroRNAs are single-stranded RNAs of 19 to 24 nucleotides in length generated through a complex maturation process. Recent studies have demonstrated that microRNAs can have an oncogene or tumor suppressor role by regulating the expression of target genes. Therefore, microRNAs are highly related to cancer processes, including initiation, growth, apoptosis, invasion, and metastasis. In this panorama, several high-through put technologies studies have revealed miRNA roles in classifying tumors and predicting patient outcome with high accuracy. We provide a review highlighting recent progress on the understanding of the cellular function of human microRNAs and their expression in solid tumors.
Similar articles
-
The roles of microRNA in cancer and apoptosis.Biol Rev Camb Philos Soc. 2009 Feb;84(1):55-71. doi: 10.1111/j.1469-185X.2008.00061.x. Epub 2008 Nov 22. Biol Rev Camb Philos Soc. 2009. PMID: 19046400 Review.
-
MicroRNA expression and function in cancer.Trends Mol Med. 2006 Dec;12(12):580-7. doi: 10.1016/j.molmed.2006.10.006. Epub 2006 Oct 30. Trends Mol Med. 2006. PMID: 17071139 Review.
-
OncomiRs: the discovery and progress of microRNAs in cancers.Mol Cancer. 2007 Sep 25;6:60. doi: 10.1186/1476-4598-6-60. Mol Cancer. 2007. PMID: 17894887 Free PMC article. Review.
-
MicroRNA-modulated autophagic signaling networks in cancer.Int J Biochem Cell Biol. 2012 May;44(5):733-6. doi: 10.1016/j.biocel.2012.02.004. Epub 2012 Feb 10. Int J Biochem Cell Biol. 2012. PMID: 22342941 Review.
-
The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis.Eur J Cancer. 2011 May;47(8):1127-37. doi: 10.1016/j.ejca.2011.02.008. Epub 2011 Mar 12. Eur J Cancer. 2011. PMID: 21402473 Review.
Cited by
-
Translational Potential of Epigenetic-Based Markers on Fine-Needle Aspiration Thyroid Specimens.Front Med (Lausanne). 2021 Mar 23;8:640460. doi: 10.3389/fmed.2021.640460. eCollection 2021. Front Med (Lausanne). 2021. PMID: 33834032 Free PMC article. Review.
-
Over-expression of miR-10b in NPC patients: correlation with LMP1 and Twist1.Tumour Biol. 2015 May;36(5):3807-14. doi: 10.1007/s13277-014-3022-6. Epub 2015 Jan 20. Tumour Biol. 2015. PMID: 25597482
-
miR-361-5p inhibits glioma migration and invasion by targeting SND1.Onco Targets Ther. 2018 Aug 28;11:5239-5252. doi: 10.2147/OTT.S171539. eCollection 2018. Onco Targets Ther. 2018. PMID: 30214229 Free PMC article.
-
MicroRNA-106b-5p (miR-106b-5p) suppresses the proliferation and metastasis of cervical cancer cells via down-regulating fibroblast growth factor 4 (FGF4) expression.Cytotechnology. 2022 Aug;74(4):469-478. doi: 10.1007/s10616-022-00536-0. Epub 2022 Jun 6. Cytotechnology. 2022. PMID: 36110154 Free PMC article.
-
Exosomal miR-106b-5p derived from melanoma cell promotes primary melanocytes epithelial-mesenchymal transition through targeting EphA4.J Exp Clin Cancer Res. 2021 Mar 19;40(1):107. doi: 10.1186/s13046-021-01906-w. J Exp Clin Cancer Res. 2021. PMID: 33741023 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources